Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Heidegger

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Der Anaesthesist|February 1, 1992
[Hereditary prolonged QT interval (Romano-Ward syndrome) in a female patient with non-elective cesarean section]J Plötz, H Heidegger, R von Hugo, et al.
Journal of Reproductive Immunology|April 1, 2026
Placental immune cell distributions of CD4, CD8 and CD56 in the context of SARS-CoV-2 infection and vaccinationF Ganster, C Hafner, L Hahn, et al.
International Journal of Molecular Sciences|April 5, 2020
Placental Galectin-2 Expression in Gestational Diabetes: A Systematic, Histological AnalysisPaula Hepp, Laura Unverdorben, Stefan Hutter, et al.
International Journal of Molecular Sciences|February 11, 2023
Expression of Progesterone Receptor A as an Independent Negative Prognosticator for Cervical CancerFabian Garrido, Carl Mathis Wild, Udo Jeschke, et al.
Journal of Cancer Research and Clinical Oncology|January 23, 2023
MTA1 as negative prognostic marker in vulvar carcinomaGiulia Wanka, Julia Jueckstock, Carl Mathis Wild, et al.
Journal of Cancer Research and Clinical Oncology|June 4, 2020
Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)Yao Ye, Lin Peng, Aurelia Vattai, et al.
Cancers|April 3, 2021
EP4 as a Negative Prognostic Factor in Patients with Vulvar CancerAnna Buchholz, Aurelia Vattai, Sophie Fürst, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer PatientsNadine Ansorge, Christian Dannecker, Udo Jeschke, et al.
European Journal of Gynaecological Oncology|August 22, 2008
Differential gene expression analysis of ovarian cancer in a population isolateD Grazio, I Pichler, C Fuchsberger, et al.
Journal of Cancer Research and Clinical Oncology|November 27, 2022
Prostaglandin E2 receptor EP1 expression in vulvar cancerAnna Buchholz, Aurelia Vattai, Sophie Fürst, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Der Anaesthesist|February 1, 1992
[Hereditary prolonged QT interval (Romano-Ward syndrome) in a female patient with non-elective cesarean section]J Plötz, H Heidegger, R von Hugo, et al.
Journal of Reproductive Immunology|April 1, 2026
Placental immune cell distributions of CD4, CD8 and CD56 in the context of SARS-CoV-2 infection and vaccinationF Ganster, C Hafner, L Hahn, et al.
International Journal of Molecular Sciences|April 5, 2020
Placental Galectin-2 Expression in Gestational Diabetes: A Systematic, Histological AnalysisPaula Hepp, Laura Unverdorben, Stefan Hutter, et al.
International Journal of Molecular Sciences|February 11, 2023
Expression of Progesterone Receptor A as an Independent Negative Prognosticator for Cervical CancerFabian Garrido, Carl Mathis Wild, Udo Jeschke, et al.
Journal of Cancer Research and Clinical Oncology|January 23, 2023
MTA1 as negative prognostic marker in vulvar carcinomaGiulia Wanka, Julia Jueckstock, Carl Mathis Wild, et al.
Journal of Cancer Research and Clinical Oncology|June 4, 2020
Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)Yao Ye, Lin Peng, Aurelia Vattai, et al.
Cancers|April 3, 2021
EP4 as a Negative Prognostic Factor in Patients with Vulvar CancerAnna Buchholz, Aurelia Vattai, Sophie Fürst, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer PatientsNadine Ansorge, Christian Dannecker, Udo Jeschke, et al.
European Journal of Gynaecological Oncology|August 22, 2008
Differential gene expression analysis of ovarian cancer in a population isolateD Grazio, I Pichler, C Fuchsberger, et al.
Journal of Cancer Research and Clinical Oncology|November 27, 2022
Prostaglandin E2 receptor EP1 expression in vulvar cancerAnna Buchholz, Aurelia Vattai, Sophie Fürst, et al.
Pageof 4